Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Current Opinion in Pharmacology|August 25, 2012
Cholesterol epoxide hydrolase and cancerSandrine Silvente-Poirot, Marc PoirotBiochimie|May 23, 2012
Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancerMarc Poirot, Sandrine Silvente-PoirotBiochemical Pharmacology|February 8, 2018
The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancersMarc Poirot, Sandrine Silvente-PoirotBiochemical Society Transactions|April 13, 2016
When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metaboliteMarc Poirot, Sandrine Silvente-PoirotCurrent Medicinal Chemistry|July 17, 2015
Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating PropertiesFlorence Dalenc, Marc Poirot, Sandrine Silvente-PoirotBiochimie|July 6, 2013
Emerging concepts on the role of exosomes in lipid metabolic diseasesMichel Record, Marc Poirot, Sandrine Silvente-PoirotCancer Research|August 19, 2018
The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in CancerSandrine Silvente-Poirot, Florence Dalenc, Marc PoirotBiochemical and Biophysical Research Communications|February 11, 2014
One step synthesis of 6-oxo-cholestan-3β,5α-diolMaud Voisin, Sandrine Silvente-Poirot, Marc PoirotCurrent Medicinal Chemistry. Anti-Cancer Agents|December 8, 2004
Multiple targeting by the antitumor drug tamoxifen: a structure-activity studyPhilippe de Médina, Gilles Favre, Marc PoirotAgeing Research Reviews|March 30, 2022
Oxysterols are potential physiological regulators of ageingPhilippe de Medina, Sandrine Silvente-Poirot, Marc PoirotPageof 9